Pediatric Dermatology

New York - The increased pigment in darker skin types helps protect women of color against photodamage, but poses other important cosmetic issues for this patient population, says Valerie D. Callender, M.D.

Internationally recognized researcher, Alan Menter, M.D., considers the future of psoriasis treatment.

Albert Kligman, M.D., Ph.D., is a pioneer who continues to break new ground in dermatology.

Stanford, Calif. - Skin cancer in immunosuppressed solid organ transplant recipients is a significant problem and one of growing importance as patient survival post-transplantation continues to increase, says Daniel Berg, M.D

Many approaches now available to rejuvenate upper, lower face

Dilution, needle selection, patient assessment and proper technique yield quality results

Doctors' expertise grows; patient confidence climbs; options broaden

Uses explode across medical specialties

Victoria, British Columbia - Sometimes what we accept as fact isn't actually reality. The truth in pediatric dermatology is turning out to be a bit different in some conditions than was taken for granted just a few years ago.

Cleveland - When thinking of pediatric fungal diseases, the mind may immediately turn toward the scalp and the typical presentation of tinea capitis. Yet fungal diseases often masquerade in several forms in various areas of the body, making the dermatologist's job of diagnosis and treatment more complicated.

Washington -Allergic contact dermatitis (ACD) has an appreciable, detrimental effect on quality of life, according to the results of a survey presented by Donald V. Belsito, M.D., at the annual meeting of the American Academy of Dermatology.

They are not the most common of dermatitis types that dermatologists typically see in their practices, but asteatotic dermatitis and neurodermatitis are driving some people to seek relief from their doctors.

A controversial report suggests that Britons should sunbathe daily without sunblock to help prevent disease.

The U.S. Food and Drug Administration (FDA) is warning the public about "adverse events" associated with some "permanent" makeup treatments.

Leeches may now officially be used for medicinal purposes, following recent approval by the U.S. Food and Drug Administration (FDA) for commercial marketing.

Safe, cost-effective filler ideal for correcting large defects

Even small modifications to verbiage, sentence structure streamline process

It is our responsibility to make people feel good about their encounters with us, even if it means biting our lips in silent frustration.

Washington - Treatment of vitiligo has advanced significantly recently, although older therapies still retain an important place in the management of this therapeutically challenging disease, says Pearl E. Grimes, M.D.

Non-genital warts continue to be almost as common as acne in the dermatology practice, according to Dr. Beutner.

Grow, preserve wealth while reducing risk, improving performance

Antigenics Inc. has announced its experimental cancer vaccine Oncophage improved post-surgery results for patients with metastatic melanoma, with one of 18 patients remaining disease-free for almost 15 months.

What's the average closing rate for U.S. dermatology practices? Mr. Atwood suspects it could be as low as 10 to 20 percent in some practices.

In a continuing series from Dermatology Times, a panel of pediatric masters discusses treatment options for specific and unusual cases. This third case is that of a 15-month-old male brought in by his mother for management of perianal warts. What are the various treatment options for the child?

Washington -A Canadian study of 515 patients with atopic dermatitis showed that treatment with Elidel cream significantly reduced patients' use of medical resources over the six-month study period and had a positive impact on the quality of life of atopic dermatitis patients in all age groups examined.

Port Charlotte, Fla. - Stephen Chiarello, M.D., is on a mission to bring dermatology into the 21st century.

Researchers now trying to determine how to deactivate newly discovered cells

Insight, appreciation are key to clinical application

Portland, OR - In a small study of bexarotene gel treatment for chronic severe hand dermatitis (HD), the medication achieved both speedy and surprising results. In a 55-patient, phase 1-2 open-label randomized clinical study of the gel, used alone and in combination with one of two steroids, 79 percent of patients on monotherapy achieved clinical improvement of at least 50 percent, and 39 percent reached at least 90 percent clearance.

Better labeling could ease confusion for patients, providers